Skip to main content
HOUSE 601116th CongressReferred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Medical Cannabis Research Act of 2019

Last Action
3/4/2019

Actions

  • 2019-03-04Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • 2019-02-08Referred to the Subcommittee on Health.
  • 2019-01-25Referred to the Subcommittee on Health.
  • 2019-01-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-01-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-01-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-01-16Introduced in House
  • 2019-01-16Introduced in House

CRS Summary

As of 2019-01-16 (00)

Medical Cannabis Research Act of 2019

This bill establishes a new, separate registration process for manufacturers of cannabis for research.

As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.

The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.

Cosponsors (12)

  • Darren Soto (D-FL)
  • Jimmy Panetta (D-CA)
  • Ken Buck (R-CO)
  • DIANA DEGETTE (D-CO)
  • Scott Peters (D-CA)
  • W. Steube (R-FL)
  • Charlie Crist (D-FL)
  • Chellie Pingree (D-ME)
  • David Joyce (R-OH)
  • Mary Scanlon (D-PA)
  • Rodney Davis (R-IL)
  • Joe Cunningham (D-SC)

Subjects

  • Drug safety, medical device, and laboratory regulation
  • Drug trafficking and controlled substances
  • Health programs administration and funding
  • Licensing and registrations
  • Medical research
  • Veterans' medical care
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.